|
⚲
|
| Keyboard |
| Harper Molly
✚
|
|
|---|---|
| CIK # | 0001871470 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001871470] | |
| 4 | [0001871470] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catalyst Pharmaceuticals Inc | |
| Harper Molly |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-12-29 | Option exercise | 1,334 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-12-29 | Option exercise | 1,334 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-12-12 | Sell | 6,746 | $23.06 | 155,563 |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-12-12 | Option exercise | 20,000 | $5.78 | 115,600 |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-12-12 | Sell | 15,527 | $23.20 | 360,226 |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2025-12-12 | Option exercise | 20,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2025-12-12 | Sell | 4,473 | $23.73 | 106,144 |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-12-08 | Option exercise | 1,413 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-12-08 | Option exercise | 1,413 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-11-21 | Option exercise | 947 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-11-21 | Option exercise | 947 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-11-20 | Grant | 5,468 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2025-11-20 | Grant | 18,115 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-02-14 | Option exercise | 4,000 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-02-14 | Option exercise | 4,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-12-27 | Option exercise | 1,333 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-12-27 | Option exercise | 1,333 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-12-09 | Option exercise | 1,413 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-12-09 | Option exercise | 1,413 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2024-11-27 | Option exercise | 17,500 | $5.78 | 101,150 |
| showing 20 of 41 most recent transactions | |||||